Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for... see more

Recent & Breaking News (CSE:AION)

Aion Therapeutic Files Five Patents with the United States Patent and Trademark Office

Newsfile September 3, 2020

Aion Therapeutic's Dr. Stephen D. Barnhill to Present at Microdose "Psychedelic Capital Series" on September 3, 2020

Newsfile August 31, 2020

CSE Bulletin: Name and Symbol Change - Osoyoos Cannabis Inc. (OSO)

Newsfile August 27, 2020

Osoyoos Announces Name Change to "Aion Therapeutic Inc."

Newsfile August 27, 2020

Osoyoos Provides Board Update; Approves Name Change

Newsfile August 19, 2020

Osoyoos Retains Integrity Media for Investor Relations and Corporate Communications

Newsfile August 12, 2020

Osoyoos Announces Results of Annual and Special Meeting

Newsfile August 10, 2020

Osoyoos Closes Non-Brokered Private Placement

Newsfile August 4, 2020

Osoyoos Closes Tranche of Non-Brokered Private Placement

Newsfile July 20, 2020

Osoyoos Provides Corporate Update on AI Pharma Acquisition

Newsfile July 8, 2020

Osoyoos Announces Closing of Acquisition of AI Pharmaceuticals Jamaica Limited

Newsfile June 30, 2020

Osoyoos Announces Agreement to Acquire AI Pharmaceuticals Jamaica Limited

Newsfile June 26, 2020

Osoyoos Announces Non-Brokered Private Placement

Newsfile June 16, 2020

Osoyoos Provides Update on Annual and Special Meeting

Newsfile June 4, 2020

Osoyoos' Extraction Systems Now Commissioned and Approved

Newsfile May 26, 2020

Osoyoos Enters into Equipment Lease and Joint-Venture Agreement; Provides Corporate Update

Newsfile April 21, 2020

Osoyoos Provides Corporate Update; Announces Board and Management Changes

Newsfile January 20, 2020

Osoyoos Announces Debt Settlement

Newsfile September 23, 2019

IIROC Trade Resumption - OSO

Canada NewsWire September 6, 2019

Osoyoos Resumes Trading

Newsfile September 5, 2019